A randomized, parallel-group, phase 2 dose-finding study to evaluate the effects of BA058 in the treatment of postmenopausal women with osteoporosis
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2017
At a glance
- Drugs Abaloparatide (Primary) ; Teriparatide
- Indications Postmenopausal osteoporosis
- Focus Biomarker; Therapeutic Use
- Sponsors Radius Health Inc.
- 10 Jun 2017 Biomarkers information updated
- 08 Mar 2015 Post hoc analysis (Trabecular Bone Score) results presented at The 97th Annual Meeting of the Endocrine Society.
- 24 Nov 2014 Results published in a Radius Health media release and also published online in the Journal of Clinical Endocrinology & Metabolism.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History